WEBVTT

0
00:00:07.000 --> 00:00:12.000
A number of assays, antibodies and platforms are available 

1
00:00:12.000 --> 00:00:15.000
for the assessment of CLDN18.2 expression.

2
00:00:15.000 --> 00:00:21.000
CLDN18.2 analysis can be performed using standard immunohistochemistry methodology.  

3
00:00:21.000 --> 00:00:26.000
Guidelines recommend that laboratories validate and/or verify immunohistochemical tests

4
00:00:26.000 --> 00:00:32.000
before placing them into clinical service and should include positive, negative and borderline tissue

5
00:00:32.000 --> 00:00:35.000
reflecting the intended use of the assay.